Imran Mohammad

This study uses CRISPR activation screening to identify surface ligands that regulate tumor sensitivity to NK cell killing, revealing new targets for improving NK cell-based immunotherapies.

LabOS is an AI co-scientist that integrates computational reasoning with physical experimentation through multimodal perception and human-AI collaboration, enhancing scientific discovery in biomedical and materials science.

This study identifies ACTL6A as a regulator of hypoxic adaptation and metabolic plasticity in head and neck squamous cell carcinoma by modulating AP-1 signaling and chromatin structure.